-
AN EFFECTIVE METHODOLOGICAL FRAMEWORK FOR EXECUTING MULTINATIONAL, PATIENT-CENTRED CROSS-SECTIONAL SURVEYS IN RARE DISEASES: FACILITATING EVIDENCE GENERATION WITH GENERALISABILITY ACROSS CONDITIONS TO SUPPORT COMMERCIAL VIABILITY
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT (HTA): CURRENT APPLICATIONS, LIMITATIONS, AND IMPLICATIONS FOR LIVING-HTA
Mar 18, 2026, 21:38 PM -
USER EVALUATION OF AN AGENTIC AI ASSISTANT FOR REAL-WORLD EVIDENCE FEASIBILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
PREDICTING OVERALL SURVIVAL FROM SURROGATE ENDPOINTS: A TWO-STAGE BAYESIAN META-ANALYTIC SURROGACY FRAMEWORK INCORPORATING RECOVERED INDIVIDUAL-LEVEL DEPENDENCE INFORMATION
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF OCTOCOG ALFA VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS IN CENTRAL AMERICA, ECUADOR AND PERÚ
Mar 18, 2026, 21:38 PM -
EVOLUTION OF PATIENT-REPORTED BURDEN AND UNMET NEEDS IN HEREDITARY ANGIOEDEMA: A COMPARATIVE SOCIAL MEDIA LISTENING ANALYSIS
Mar 18, 2026, 21:38 PM -
PREVALENCE OF DEPRESSION AMONG ADULTS WITH SICKLE CELL DISEASE IN TEXAS MEDICAID
Mar 18, 2026, 21:38 PM -
REAL-WORLD EPIDEMIOLOGY, CLINICAL OUTCOMES AND PATIENT SATISFACTION AMONG USERS OF ARTIFICIAL PANCREAS SYSTEMS IN TYPE 1 AND TYPE 2 DIABETES INSIGHTS FROM PHYSICIAN NOTES USING NLP
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH AND GLP-1 PRESCRIBING PATTERNS IN T2D AND OBESITY: REAL-WORLD EVIDENCE FROM A LARGE, NATIONAL U.S. LINKED EHR-CLAIMS NETWORK
Mar 18, 2026, 21:38 PM -
REAL-WORLD BUDGET IMPACT ANALYSIS OF BIOSIMILAR ADOPTION IN A MEDIUM-SIZED BRAZILIAN HEALTH MAINTENANCE ORGANIZATION (HMO)
Mar 18, 2026, 21:38 PM -
WHEN NOT TO USE ARTIFICIAL INTELLIGENCE IN HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS AND HARMS OF SUSTAINED STATIN THERAPY AMONG YOUNG ADULTS
Mar 18, 2026, 21:38 PM -
IMPACT OF METHOD CHOSEN FOR DEFINING OBSERVABLE TIME IN LINKED OPEN DATA SOURCES
Mar 18, 2026, 21:38 PM -
FROM WEEKS TO DAYS: MULTI-AGENTIC AI SYSTEM FOR AUTOMATED DEVELOPMENT OF HTA-READY HEALTH ECONOMIC MODELS
Mar 18, 2026, 21:38 PM -
EASE OF USE OF TIRZEPATIDE: RESULTS FROM A US SURVEY OF INDIVIDUALS WITH OBESITY OR OVERWEIGHT
Mar 18, 2026, 21:38 PM -
TRANSLATING LONG-TERM RISK REDUCTION WITH ROPEGINTERFERON ALFA-2B INTO PATIENT AND ECONOMIC IMPACT IN POLYCYTHEMIA VERA
Mar 18, 2026, 21:38 PM -
THE IMPACTS OF TEEN BIRTH ON FEMALE ECONOMIC OUTCOMES: EVIDENCE FROM ABORTION ACCESS DATA
Mar 18, 2026, 21:38 PM -
MAPPING QUALITY-OF-LIFE INSTRUMENTS IN JAPANESE HTA SUBMISSIONS: CURRENT PRACTICES AND FUTURE DIRECTIONS
Mar 18, 2026, 21:38 PM -
AUTOMATED PERITONEAL DIALYSIS (APD) VS HEMODIALYSIS (HD) IN CHINA: COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA COMPLETENESS IN TYPE 2 DIABETES THROUGH LINKAGE OF CLAIMS, EMR, AND LABORATORY DATA
Mar 18, 2026, 21:38 PM
